LifeMD Price Cash Flow Ratio vs Cash Flow To Debt Ratio Analysis
| LFMD Stock | USD 5.17 0.01 0.19% |
LifeMD financial indicator trend analysis is infinitely more than just investigating LifeMD Inc recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether LifeMD Inc is a good investment. Please check the relationship between LifeMD Price Cash Flow Ratio and its Cash Flow To Debt Ratio accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in LifeMD Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
Price Cash Flow Ratio vs Cash Flow To Debt Ratio
Price Cash Flow Ratio vs Cash Flow To Debt Ratio Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of LifeMD Inc Price Cash Flow Ratio account and Cash Flow To Debt Ratio. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between LifeMD's Price Cash Flow Ratio and Cash Flow To Debt Ratio is -0.16. Overlapping area represents the amount of variation of Price Cash Flow Ratio that can explain the historical movement of Cash Flow To Debt Ratio in the same time period over historical financial statements of LifeMD Inc, assuming nothing else is changed. The correlation between historical values of LifeMD's Price Cash Flow Ratio and Cash Flow To Debt Ratio is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Price Cash Flow Ratio of LifeMD Inc are associated (or correlated) with its Cash Flow To Debt Ratio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash Flow To Debt Ratio has no effect on the direction of Price Cash Flow Ratio i.e., LifeMD's Price Cash Flow Ratio and Cash Flow To Debt Ratio go up and down completely randomly.
Correlation Coefficient | -0.16 |
| Relationship Direction | Negative |
| Relationship Strength | Insignificant |
Price Cash Flow Ratio
Cash Flow To Debt Ratio
Most indicators from LifeMD's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into LifeMD Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in LifeMD Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. At present, LifeMD's Discontinued Operations is projected to increase significantly based on the last few years of reporting. The current year's Tax Provision is expected to grow to about 516.8 K, whereas Sales General And Administrative To Revenue is forecasted to decline to 0.37.
| 2022 | 2023 | 2024 | 2025 (projected) | Interest Expense | 1.3M | 2.6M | 3.0M | 3.1M | Depreciation And Amortization | 3.8M | 6.6M | 7.6M | 8.0M |
LifeMD fundamental ratios Correlations
Click cells to compare fundamentals
LifeMD Account Relationship Matchups
High Positive Relationship
High Negative Relationship
LifeMD fundamental ratios Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Total Assets | 13.1M | 49.9M | 25.7M | 58.5M | 67.3M | 70.6M | |
| Short Long Term Debt Total | 1.1M | 1.8M | 4.1M | 18.9M | 21.8M | 22.9M | |
| Other Current Liab | 1.6M | 10.0M | 8.9M | 11.4M | 13.2M | 13.8M | |
| Total Current Liabilities | 13.5M | 22.8M | 31.4M | 34.8M | 40.0M | 42.0M | |
| Total Stockholder Equity | 1.4M | 26.9M | (6.8M) | 3.5M | 4.0M | 2.1M | |
| Property Plant And Equipment Net | 274.4K | 2.0M | 1.7M | 1.1M | 1.2M | 678.9K | |
| Net Debt | (8.1M) | (39.5M) | 168.5K | (14.2M) | (12.8M) | (12.2M) | |
| Retained Earnings | (80.2M) | (141.9M) | (190.6M) | (214.3M) | (192.8M) | (183.2M) | |
| Accounts Payable | 10.4M | 9.1M | 10.1M | 11.1M | 12.7M | 13.4M | |
| Cash | 9.2M | 41.3M | 4.0M | 33.1M | 38.1M | 40.0M | |
| Non Current Assets Total | 990.3K | 5.0M | 14.4M | 15.9M | 18.3M | 19.2M | |
| Cash And Short Term Investments | 9.2M | 41.3M | 4.0M | 33.1M | 38.1M | 40.0M | |
| Net Receivables | 997.8K | 980.1K | 2.8M | 5.3M | 6.1M | 6.4M | |
| Common Stock Total Equity | 534.0K | 234.3K | 307.0K | 315.5K | 362.9K | 377.1K | |
| Common Stock Shares Outstanding | 14.3M | 27.0M | 31.0M | 33.9M | 39.0M | 40.9M | |
| Liabilities And Stockholders Equity | 13.1M | 49.9M | 25.7M | 58.5M | 67.3M | 70.6M | |
| Non Current Liabilities Total | 385.3K | 1.3M | 1.6M | 18.1M | 20.9M | 21.9M | |
| Inventory | 1.3M | 1.6M | 3.7M | 2.8M | 3.2M | 3.3M | |
| Other Stockholder Equity | 77.6M | 164.4M | 178.9M | 217.4M | 250.0M | 262.5M | |
| Total Liab | 13.9M | 24.1M | 33.0M | 52.9M | 60.9M | 63.9M | |
| Property Plant And Equipment Gross | 274.4K | 2.0M | 1.7M | 1.1M | 1.2M | 678.9K | |
| Total Current Assets | 12.1M | 44.9M | 11.3M | 42.6M | 49.0M | 51.4M | |
| Short Term Debt | 872.1K | 1.3M | 4.3M | 930.8K | 1.1M | 848.5K | |
| Common Stock | 234.3K | 307.0K | 315.5K | 383.6K | 441.1K | 380.6K | |
| Non Currrent Assets Other | (990.3K) | (5.0M) | (14.4M) | (1.0) | (0.9) | (0.94) | |
| Other Current Assets | 1.8M | 996.7K | 814.3K | 1.9M | 2.2M | 2.3M | |
| Current Deferred Revenue | 916.9K | 1.5M | 5.5M | 8.8M | 10.2M | 10.7M | |
| Net Tangible Assets | (1.7M) | (3.0M) | 19.7M | (19.5M) | (17.6M) | (16.7M) | |
| Net Invested Capital | (1.5M) | 22.8M | (8.6M) | 21.8M | 25.0M | 26.3M | |
| Short Long Term Debt | 779.1K | 63.4K | 2.8M | 327.6K | 376.7K | 357.9K | |
| Net Working Capital | (1.4M) | 22.1M | (20.1M) | 7.8M | 9.0M | 9.4M | |
| Capital Stock | 3.9M | 4.4M | 4.9M | 383.7K | 441.3K | 419.2K | |
| Intangible Assets | 715.8K | 3.0M | 12.7M | 14.8M | 17.0M | 17.9M | |
| Capital Lease Obligations | 285.3K | 1.8M | 1.3M | 677.0K | 778.6K | 903.9K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether LifeMD Inc is a strong investment it is important to analyze LifeMD's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact LifeMD's future performance. For an informed investment choice regarding LifeMD Stock, refer to the following important reports:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in LifeMD Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of LifeMD. If investors know LifeMD will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about LifeMD listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.66) | Revenue Per Share | Quarterly Revenue Growth 0.383 | Return On Assets | Return On Equity |
The market value of LifeMD Inc is measured differently than its book value, which is the value of LifeMD that is recorded on the company's balance sheet. Investors also form their own opinion of LifeMD's value that differs from its market value or its book value, called intrinsic value, which is LifeMD's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because LifeMD's market value can be influenced by many factors that don't directly affect LifeMD's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between LifeMD's value and its price as these two are different measures arrived at by different means. Investors typically determine if LifeMD is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, LifeMD's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.